FDA Inspection
Ther-RX CorporationTher-RX Corporation – FDA Inspection, Feb 2, 2009
Record Details
This FDA Inspection record concerns Ther-RX Corporation, with an inspection on February 2, 2009, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Ther-RX Corporation
- Inspection Date
- February 2, 2009
- Product Type
- Drugs
View Company Profile
ID · 1a581c79-f8a8-49ba-a7b0-3d2a50e5d6b9
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 554861
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Ther-RX Corporation
5| Date | Classification | Office | Project area |
|---|---|---|---|
| February 26, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 22, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 11, 2011 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| February 11, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 20, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Ther-RX Corporation
- FDA Inspection 915593 - 2015-02-26
- FDA Inspection 829562 - 2013-02-22
- FDA Inspection 714035 - 2011-03-11
- FDA Inspection 709497 - 2011-02-11
- FDA Inspection 677252 - 2010-08-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.